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Abstract
Calorie restriction (CR) remains the most robust intervention to extend life span and improve health span. Using a global mass spectrometry–
based metabolomics approach, we identified metabolites that were significantly differentially expressed in the plasma of C57BL/6 mice, fed 
graded levels of calorie restriction (10% CR, 20% CR, 30% CR, and 40% CR) compared with mice fed ad libitum for 12 hours a day. The 
differential expression of metabolites increased with the severity of CR. Pathway analysis revealed that graded CR had an impact on vitamin 
E and vitamin B levels, branched chain amino acids, aromatic amino acids, and fatty acid pathways. The majority of amino acids correlated 
positively with fat-free mass and visceral fat mass, indicating a strong relationship with body composition and vitamin E metabolites correlated 
with stomach and colon size, which may allude to the beneficial effects of investing in gastrointestinal organs with CR. In addition, metabolites 
that showed a graded effect, such as the sphinganines, carnitines, and bile acids, match our previous study on liver, which suggests not only that 
CR remodels the metabolome in a way that promotes energy efficiency, but also that some changes are conserved across tissues.
Keywords: Metabolomics, Calorie restriction, Aging, Vitamin E, Amino acids, Bile acids
Aging and age-associated diseases are the primary cause of mortality 
in developed countries and are on the rise in developing countries, 
where the rate of population aging is accelerating faster than the 
developed countries in the past (1–3). Consequently, we need to find 
innovative ways to sustain “healthy aging” to manage our aging pop-
ulations. Calorie restriction (CR) can delay and reverse the effects of 
aging in a wide range of organisms including Caernahabditis ele-
gans, Drosophila melanogaster, fish, rodents, nonhuman primates, 
and possibly even humans (4). In rodents, decreasing calorie intake 
from 0% to 65% is linearly associated with increasing life span (5). 
As the life span–extending effect of CR increases with higher lev-
els of CR, a study design involving graded levels of CR is useful to 
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identify potential biological pathways that may be important to the 
beneficial effects of CR on aging. Recently, the use of graded CR has 
become a popular approach (6–8).
Focusing on plasma provides a means to take an integrative view 
of changes across different organs. Plasma facilitates the detoxifica-
tion and removal of waste products, maintains water and salt balance, 
and transports nutrients between organs. As plasma can be readily 
sampled, it is ideal for metabolomic biomarker discovery and has been 
used for many diseases including liver cirrhosis and liver carcinoma 
(9), breast cancer (10), and pulmonary arterial hypertension (11). 
Liquid chromatography–mass spectrometry provides sensitive detec-
tion of metabolites. Using a broad-spectrum metabolomic platform 
for untargeted analysis allows the detection of metabolites that may 
not have been previously associated with CR and aging. Previously, 
metabolomic analyses of the liver from mice on graded CR indicated 
that CR is associated with an increase in carnitines, phospholipids, and 
bile acids, indicating that under higher levels of CR, the liver becomes 
increasingly efficient at breaking down and metabolizing lipids (12).
Plasma metabolomic profiles show age-related changes in protein 
and vitamin levels (13). In particular, vitamin E exhibits a significant 
decrease in its several forms, with plasma γ-tocopherol and the plate-
let α-tocopherol, γ-tocopherol, and total tocopherol concentrations 
decreasing significantly with age (14). Global plasma metabolomics 
of mice at 30% CR have shown changes in amino acid profiles, lac-
tate, cholesterol, and low-density lipoproteins after only 48 hours of 
40% of CR in C57BL/6 mice (15).
In this study, we determined differential metabolite expression 
between a control group fed ad libitum during the 12 hours of dark-
ness each 24-hour cycle (12AL), a control group fed ad libitum 24 
hours a day (24AL), and CR groups (10% CR–40% CR). Our goal 
was to detect metabolites and pathway changes with CR. Looking 
at each individual CR group allowed us to detect nonlinear changes 
such as those that have a threshold level. We also aimed to determine 
whether any metabolites or pathways changed in a linear fashion 
with increasing restriction, as these changes may mirror the relation-
ship between life span and CR.
Experimental Procedures
Experimental Design
Our dataset consisted of metabolomic data from technical duplicates 
of 46 individual plasma samples. Mice were allocated to six treatment 
groups: control (12AL: 12-hour ad libitum feeding during the hours of 
darkness only and 24AL: 24-hour ad libitum feeding) and 10% CR, 
20% CR, 30% CR, and 40% CR (percentage of calories less than indi-
vidual average food intakes measured over a 2-week baseline period) 
for 3 months (10CR, 20CR, 30CR, and 40CR, respectively). Sample 
size was eight for all groups except 24AL and 30CR where n = 7. We 
initiated CR at 20 weeks; this was done to avoid any effect of CR on 
development while retaining effectiveness of increasing life span.
Animals
Five-month-old C57BL/6 male mice were used (16). All procedures 
were reviewed and approved by University of Aberdeen ethical 
approval committee and carried out under a Home Office issued 
license compliant with the Animals (Scientific Procedures) Act 1986. 
This strain is already known to live longer under CR (17). Mice 
were purchased from Charles River (Ormiston, UK). Free access to 
water was provided. More detailed information on study design can 
be found in Supplementary S1 and in the study by Mitchell and col-
leagues (16).
Liquid Chromatography–Mass Spectrometry
Metabolite features were identified with dual chromatography–
Fourier transform mass spectrometry (DC-FTMS) using electrospray 
ionization in the positive mode. Replicates were run at the same 
time, and samples were run in a randomized order. Samples were run 
in two batches. Methodology on the dual chromatography–liquid 
chromatography–mass spectrometry procedure can be found in 
ref. (18) and in Supplementary S2. A Thermo LTQ-FT mass spec-
trometer (linear ion trap with a Fourier Transform Ion Cyclotron 
Resonance [FT-ICR] MS detector, Thermo Fischer, San Diego, CA) 
was set to collect data between 85 and 850 m/z (mass–charge ratio).
Metabolomic Preprocessing
As metabolites, even within samples, show a significant amount of sto-
chastic variation, it is necessary to filter out “noisy,” uninformative metab-
olites. First, metabolites were normalized using a log 2 transformation. 
Second, only metabolites with a signal-to-noise ratio (SNRi = mean/sam-
ple SD) ≥ 15 were retained for analysis. Third, metabolites that were 
missing from 15% or more of all samples were excluded.
Statistical Modeling of Differential Metabolite 
Expression
To detect significantly differentially expressed metabolites between 
treatment groups, an empirical Bayes moderated linear model was fitted 
to each metabolite (19). The empirical Bayes approach shrinks the esti-
mated sample variances by borrowing information from across metab-
olites. Fold changes were estimated using contrasts between 12AL and 
each level of CR (10%, 20%, 30%, and 40%), plus the 24AL group. 
p Values for each comparison were adjusted using the   Benjamini-
Hochberg (BH) procedure using a false discovery rate of 5% (20). We 
used the Devium package to perform orthogonal - partial least squares - 
discriminant analysis (O-PLS-DA), to complete the validation steps and 
retrieve metabolite loadings, and to produce the biplot and scores plots 
(21) (see Supplementary S3 for more information).
Putative Identification of Metabolites
Metabolites were identified using two approaches. First, metabo-
lites were assigned using xMSannotator by the Human Metabolome 
Database (HMDB), Kyoto Encyclopaedia of Genes and Genomes 
(KEGG), and LipidMaps (22). Second, the metabolite enrichment 
program mummichog (23) was used to assign putative metabolite 
matches based on pathways that are enriched within the metabol-
ite set using a reference model derived from integration of KEGG, 
biochemically, genetically, and genomically structured (BiGG) and 
Edinburgh Human Metabolic Network (EHMN) databases.
Biological Pathway Analysis
Pathway analysis was conducted using mummichog and  ingenuity 
pathway analysis (IPA). For analysis in mummichog, features with 
unadjusted p ≤ .05 generated by the empirical Bayes linear model 
for each comparison with 12AL were utilized, along with their cor-
responding log fold changes and retention times. Metabolites iden-
tified in both mummichog and xMSannotator, in addition to their 
unadjusted p values and fold-changes were entered into IPA for ana-
lysis. Only metabolites with an ID from either KEGG or HMDB 
were used (see Supplementary S4 for more information).
Correlations With Physiological Parameters
Fat-free mass, adiposity, stomach, and colon weight (16); circulat-
ing leptin and insulin, catalase, and derivatives of reactive oxidative 
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metabolites (24); and hypothalamic transcript levels for cholinergic 
receptors (25) were correlated with log 2 transformed, normalized 
metabolite intensities for each individual mouse using Pearson’s 
correlation. Associated p values for each correlation were adjusted 
using the BH procedure using a false discovery rate of 5%.
Results
Characterization of Metabolomic Plasma Profiles 
Using Mass Spectrometry
CR was applied to male mice at 20 weeks of age for 12 weeks. 
Control mice were allowed ad libitum access to food for 12 hours 
(time-restricted feeding, 12AL) and 24 hours a day (24AL), and the 
four CR groups were given 10%, 20%, 30% and 40% restriction 
from their baseline intakes. 12AL was used as the control group for 
all further analyses to remove any potential “time since last meal 
effect” of 24AL mice, as all mice had been food deprived for at least 
7.5 hours before culling. We used DC-FTMS to detect metabolomic 
features, characterized by unique retention times and m/z ratios. 
We found that the anion exchange (AE) method detected 4,698 m/z 
features and the C18 or reverse phase method detected 3,345 m/z 
features. Although the number of m/z features across individuals dif-
fered between the AE and C18 columns, the median m/z values for 
the methods were similar (AE median m/z = 427.60; C18 median 
m/z  =  437.20 (Figure  1A). To determine the contribution of each 
column to the overall profile of metabolites detected, m/z values 
were matched between the AE and C18 feature tables (Figure 1B). 
A total of 8,043 m/z features were found in the overall profile, 27% 
of which were detected in both the AE and C18. The majority of 
the m/z features were unique to the AE analysis (47%). The C18 
analysis added 1,622 m/z features that were not detected by the AE 
separation, approximately 26%. The m/z values were filtered based 
on their replication across individuals and signal-to-noise ratio. 
Postfiltering, a total of 2,954 m/z features were present, 1.702 from 
AE and 1,252 from C18. Technical duplicates showed strong corre-
lations across all samples (AE: R = .64–.81, adjusted p < .001, C18: 
R = .63–.87 adjusted p < .001; Figure 1C). Of the filtered metabo-
lites in the AE and C18 columns, 755 and 491 features, respectively, 
were significantly differentially expressed (F statistic p < .05). As 
the level of restriction increased, the number of significantly differ-
entially expressed features also rose in both AE and C18 columns 
(Supplementary Tables 1 and 2). Subsequently, features from both 
columns were combined into a master list for subsequent analyses. 
Metabolites were identified using mummichog and xMSannotator, 
using KEGG, HMDB, LipidMaps, and T3DB. Of the 2,954 m/z val-
ues, we were able to putatively assign IDs to 713 metabolites.
Discriminant Analysis
We performed an O-PLS-DA analysis on all identified and nonidenti-
fied filtered features (n  =  2,954). The model indicated that around 
60% of the variance in the features could be explained by the dietary 
treatment (single-sample t test between model parameters and per-
muted parameters, n = 1,000, p < .001, RX2 = 58.24, Q2 = 0.8038, 
RMSEP  =  0.7518; Figure  2). Loadings from the O-PLS-DA model 
determined features that contributed to the separation of groups 
(Figure  3). Of 2,954 m/z features, 888 features contributed signifi-
cantly to discrimination between treatment groups, using a false dis-
covery rate cutoff p < .05. Of these, we were able to identify 224 
(Supplementary Table 3). The model indicated that several vitamins, 
including B2, B5, and numerous vitamin E derivatives, carnitine and 
Figure  1. (A) Histogram showing distribution of features detected in 46 
mice samples. AE: anion exchange column; C18: reverse phase column. 
(B) Venn diagram metabolites detected, overlap between columns. (C) 
Correlation of technical replicates in AE and C18 columns. Correlations were 
applied to all filtered metabolites, intensities were log2 transformed. AE: 
standardized major axis (SMA) gradient = 0.973, R = .809, p < .001. C18: SMA 
gradient = 0.980, R = .738, p < .001.
Figure 2. Orthogonal partial least square discriminate analysis (O-PLS-DA) 
demonstrates the differentiation effect of diet in metabolomic profiles. 
Loadings plot shows significant separation among samples on the basis of 
the model quality parameters: RX2, Q2, and RMSEP.
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taurine metabolites, amino acids, sphinganine, and sphinganine-
1-phosphate were important in discriminating the different CR 
groups.
Normalized metabolite intensities were correlated across each 
individual mouse between the plasma and the liver. Metabolites 
that correlated positively between the plasma and the liver included 
creatine, O-acetylcarnitine and O-propanoylcarnitine, l-methio-
nine, and 15-keto-prostaglandin E2. Plasma l-arginine was signifi-
cantly negatively correlated with intensities of the same metabolite 
in the liver.
Pathway Analysis
For 10CR, 20CR, 30CR, and 40CR, we carried out a metabolite set 
enrichment analysis using mummichog and IPA. Mummichog identi-
fies metabolites and pathways based on m/z values, fold changes, p 
values, and retention times (Supplementary Table 4). IPA identifies 
pathways using putatively identified metabolites through mummi-
chog and xMSannotator with their associated fold changes and p 
values (n = 713). Of these IDs, 321 were recognized in the IPA data-
base and were analyzed.
Changes Across Several Amino Acids
Mummichog analysis showed that features in several amino acid 
pathways altered with CR, in particular at 40CR, although there 
were modifications at all levels of restriction. The majority of fea-
tures in amino acids were decreased (Supplementary Table  5). In 
particular, decreases in features belonging to the aromatic amino 
acid pathways such as tyrosine and tryptophan were observed. 
Moreover, branched chain amino acid (BCAA) pathways in add-
ition to aspartate, asparagine, and lysine also appeared decreased. 
IPA analysis indicated that at 40CR tyrosine biosynthesis (p < 
.01), phenylalanine degradation (p < .01), and valine degradation 
(p  =  .04) were also significantly decreased. At 10CR, a different 
set of pathways appeared altered in IPA including proline biosyn-
thesis (p < .01) and leucine degradation (p = .01), which showed a 
decrease relative to 12AL.
Vitamins Classes Increased by CR
Components of the vitamin E metabolism pathway showed sig-
nificant increases at 20CR, 30CR, and 40CR (p < .01 in all cases, 
Figure 4). At 40CR, six metabolites in the vitamin D3 metabolism 
pathway and two metabolites in the cofactor vitamin B6 metabol-
ism pathway increased significantly relative to 12AL (p < .01 and 
p = .01, respectively). The vitamin D3 pathway was also significantly 
higher at 20CR with three features significantly increased (p = .03) 
compared with 12AL.
Fatty Acid Pathways Were Altered With CR
As expected with CR, many constituents of fatty acid pathways were 
increased, indicating a shift in metabolic substrate. The majority of 
features in all pathways associated with fatty acids were increased 
(Supplementary Table 6). In addition, features in the carnitine shut-
tle pathway, which is involved in transporting fatty acids across the 
mitochondrial membrane for β-oxidation, showed an increase with 
CR at both 20CR and 40CR.
Distinct Differences at 24AL
Both the IPA and mummichog analyses indicated that at a path-
way level the 24AL group was distinctly different from the CR 
groups, whereas between CR groups, there was considerable over-
lap (Figure 5). These pathways indicated a predisposition to disease 
and included disease associated pathways such as thyroid cancer 
and wnt signaling. At 24AL relative to 12AL, the vitamin A pathway 
appeared increased with two significantly increased metabolites and 
one decreased (p = .01). Notably, in contrast to the CR groups, mice 
under the 24AL control showed significant decreases in fatty acid 
metabolism (Supplementary Table 6).
Relationship Between Metabolites and Physical 
Characteristics
We correlated transformed and normalized amino acid intensi-
ties with fat-free mass to see if any potential relationships existed 
between particular amino acids and lean mass (16). We found 
that plasma amino acids mainly correlated positively with fat-free 
mass (Supplementary Table 7). However, the amino acid derivative 
S-adenosyl-l-methionine (SAM) significantly negatively correlated 
with fat-free mass (R = −.563, p < .001). We also tested for signifi-
cant correlations between amino acids and hormone levels as well 
as visceral fat. We saw that significant positive correlations existed 
between l-leucine and l-glutamate and leptin and insulin. l-Leucine, 
l-glutamate, and l-methionine also positively correlated with insu-
lin (Supplementary Table 8). In contrast, SAM correlated negatively 
with insulin (R = −.47, p = .01) and positively with tumor necrosis 
factor-α (R = −.53, p = .01).
We also investigated relationships between plasma aromatic 
amino acids and cholinergic receptor transcript levels in the hypo-
thalamus, as aromatic amino acids form the precursors of several 
catecholamines (Supplementary Table  9). We found that tyrosine, 
the substrate for dopamine synthesis, was negatively correlated with 
hypothalamic transcriptional levels of Drd5 (R  =  −.47, p  =  .03), 
a dopamine receptor expressed in the limbic regions of the brain. 
l-Phenylalanine and l-tryptophan both significantly negatively cor-
related with hypothalamic transcriptional levels of Adrbk2 (Grk3), 
a beta adrenergic receptor kinase 2 (R = .64, p = .03 and R = .23, 
p =  .01, respectively), which is thought to interact with dopamine 
(26). We also correlated BCAAs, l-leucine and l-valine, with fasting 
glucose and insulin levels (Supplementary Table 6). We found both 
BCAAs correlated significantly positively with insulin levels (l-leu-
cine: R =  .472, p =  .002; l-valine: R =  .333, P =  .036) and fasting 
glucose correlated significantly positively with l-leucine (R =  .544, 
p < .001).
We previously found that the stomach, colon, ileum, and cecum 
were invested in with CR, so we correlated normalized transformed 
Figure 3. (A) S-plot indicating in turquoise metabolites that were significantly 
contributing to differences among feeding groups (false discovery rate cutoff 
p < .05). (B) Bar plot showing the weights of those metabolites that were 
significant (turquoise).
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vitamin intensities with the weights of the digestive tract tissues. 
We found that several metabolites correlated with stomach weight 
and colon weight (Supplementary Table  10). In addition, vitamin 
E metabolites correlated negatively with oxidative stress measures 
including the antioxidant enzyme catalase but positively with hyper-
peroxides in the blood. Vitamin E metabolites also correlated nega-
tively with leptin (Supplementary Table 11).
Metabolites and Pathways Linearly Affected by CR
We used the correlation coefficients from correlation of metabo-
lites with level of CR and BH adjusted p values for each metab-
olite to observe pathways that may potentially be associated with 
life span in the plasma using mummichog (Supplementary Table 12) 
and IPA (Supplementary Table 13). Pathway analysis indicated that 
positively associated pathways included linoleate, vitamin D3 and 
E, omega-3, bile acid, and fatty acid metabolism. Negatively asso-
ciated pathways included the amino acids, glutathione, butanoate 
and sugar pathways, tyrosine biosynthesis, phenylalanine degrad-
ation, S-reticuline biosynthesis, and catecholamine biosynthesis. 
Metabolites that were significantly associated with the level of CR 
(Supplementary Table  14) include the sulfonated form of dopa-
mine, dopamine 3-sulfate. This metabolite that is the predominant 
endogenous form in plasma was significantly decreased at 40CR 
(logFC = −2.06, adjusted p < .007) and correlated negatively with 
the level of CR (R = −.609, adjusted p < .001). In addition, the dopa-
mine receptor, Drd5 measured in the hypothalamus, correlated posi-
tively with the level of CR (R  =  .499, p  =  .005). SAM correlated 
positively with the level of CR (R  =  .483, p  =  .003). Metabolites 
associated with both arachidonic and linoleic acid pathways were 
positively correlated with CR, such as anandamide, a key molecule 
in the endocannabinoid system, which was significantly increased 
at 20CR, 30CR, and 40CR and correlated positively with CR level 
(R = .513, p = .001). In addition, it also correlated positively with 
Tb (R = .480, p = .001), and although anandamide did not correlate 
Figure 4. Vitamin E metabolism pathway at 10% CR–40% CR. Bold indicates metabolite significantly differentially expressed between CR group and 12AL. Gray 
indicates metabolite not detected in sample.
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with total physical activity, it did correlated with food anticipatory 
activity (R = .541, p < .001; Supplementary Table 15). In addition, 
several metabolites that are constituents of bile acid metabolites cor-
related positively with the level of CR, despite taurine being nega-
tively correlated.
Discussion
Graded CR Provides Novel Insights Into the Effects 
of CR
In contrast to many earlier studies on the effects of CR on life span 
and health span, which have typically included a single treatment 
level, here we used graded CR treatment groups. The plasma, as 
with the liver in our previous study (12), showed an increase in sig-
nificantly differentially expressed metabolites with increasing CR. 
However, in contrast to our findings in the liver, we found a large 
number of plasma metabolites that differed between 12AL and 
24AL. This indicates that ad libitum access to food has a greater 
effect on circulating metabolite levels.
Changes in Amino Acids With CR May Have an 
Effect on Catecholamines, Insulin Resistance, 
Antioxidant Levels, and Longevity
Previous plasma metabolomic analyses on 48-hour 30% CR in 
C57BL/6 mice reported increases in several amino acids, as well as 
in creatine, and decreases in choline and glucose (15). Though we 
did see a significant decrease in glucose at 40CR, our results sug-
gest that the majority of amino acids decreased with increasing CR. 
This has been seen previously in the serum metabolomic profile of 
nude mice on 30% restriction for 4 months (27). CR has previously 
been suggested to increase the breakdown of amino acids, which can 
be converted to pyruvate for use in gluconeogenesis (28). Although 
we did not identify pyruvate (molecular weight [MW] = 88) in our 
screen perhaps due to its small size, we did see a significant decrease 
in fructose-1,6-bisphosphate, a precursor of glucose at 40CR, which 
may indicate an increase in gluconeogenesis in organs such as the 
liver and kidney. We previously reported increased levels of genes 
linked to gluconeogenesis in the livers of the same mice used in this 
experiment (29).
Our pathway analyses indicated that there were significant 
decreases in the tyrosine metabolism pathway and the tryptophan 
pathway with CR (though tryptophan levels increased). The aro-
matic amino acids, l-phenylalanine and l-tyrosine, are precursors for 
dopamine, epinephrine, and norepinephrine, and l-tryptophan is the 
precursor for serotonin (30). In addition, vitamin B6, the pathway 
of which was increased at 40CR, acts as a coenzyme for the pro-
duction of these neurotransmitters (31). We found dopamine 3-sul-
fate, which is the predominant endogenous form of dopamine in 
the plasma, negatively associated with the level of CR. In humans, 
75% of dopamine sulfate is thought to come from the gastrointes-
tinal tract through sulfoconjugation of dopamine synthesized from 
l-DOPA, and significantly increases after meals and with foods rich 
in biogenic amines (32,33).
Dopamine sulfate is thought to function physiologically as a pre-
cursor for norepinephrine through conversion to dopamine (32). 
Although dopamine 3-sulfate did not significantly correlate with the 
dopamine receptor Drd5 in the hypothalamus (R = −0.48, p = .053), 
l-tyrosine was significantly negatively correlated. Drd5 itself corre-
lated significantly positively with the level of CR, indicating that as 
mice became increasingly restricted, the level of this dopamine recep-
tor in the hypothalamus increased. The decrease in substrates and 
concurrent increase in brain dopamine receptor may indicate that 
plasma substrates are being converted into dopamine and norepin-
ephrine in the brain. CR has been shown to reduce both the loss of 
dopaminergic neurons in the substantia nigra of mice (34), and stri-
atal dopamine receptors in the brains of rats (35,36), both of which 
are associated with reducing age-associated neurodegeneration in 
conditions such a Parkinson’s disease.
Regarding BCAAs, our plasma results suggest that, l-leucine and 
l-valine were significantly decreased with increasing CR, indicating 
that BCAAs may have a negative impact on lifespan in C57BL/6 
mice. Previous studies have shown that C57BL/6J mice on a low 
BCAA diet have improved glucose and pyruvate tolerance and 
decreased fasting blood glucose and steady insulin levels (37); 
indeed, the positive relationship that we observed between BCAAs 
and fasting glucose and insulin levels supports this study.
Weight loss diets have been shown to consistently reduce levels 
of plasma amino acids in humans including BCAAs (38). It has also 
been suggested that visceral white adipose tissue may be involved 
in the accumulation of BCAAs in obese humans and mice (39). We 
found a strong relationship between several amino acids and vis-
ceral fat mass, which mirrors existing studies in obese women that 
have significantly higher circulating BCAA levels (40). In the latter 
study, it was also found that glutamate was the strongest predictor 
of visceral adiposity, and in our study, we also found l-glutamate 
correlated strongest of the amino acids. A  recent study in over-
weight humans indicated that even mild CR caused a decrease in 
both plasma l-leucine and l-phenylalanine, in concordance with the 
findings here (8). The fasting concentrations of BCAAs and aromatic 
amino acids have been shown to predict future diabetes in healthy, 
nonglycemic individuals. In some cases, an elevation of these amino 
Figure  5. Heat map showing metabolic pathways identified by Ingenuity 
Pathway Analysis (IPA). Pathways based on metabolites identified by both 
mummichog and xmsAnnotator. Black indicates pathway not present in 
group.
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acids may occur as much as 12 years before the onset of diabetes 
(41), which indicates short-term CR may be sufficient to prevent the 
onset of such metabolic disorders.
Vitamin E May Be Modulated by Hunger Signaling
Significant changes in vitamin E with CR may occur due to its role 
as a free-radical scavenging molecule. Also important is its role in 
membranes, as with age, lower levels of vitamin E have been associ-
ated with mitochondrial dysfunction through its protection of mem-
branes from oxidative stress (42). We found that several vitamin E 
metabolites were positively correlated with reactive oxygen metabo-
lites in the plasma and negatively correlated with catalase in the liver. 
This may indicate that vitamin E is increasing to mitigate increases 
in reactive oxygen metabolites in the plasma, as seen previously in 
rat hepatocytes (43).
Plasma levels of vitamin E bound in circulating lipoproteins can 
be decreased by insulin infusion in humans, independent of insulin 
sensitivity, indicating that insulin can affect the oxidant/antioxidant 
balance through vitamin E (44). In addition, vitamin E tocotrienols, 
which were increased in our analysis, can improve insulin sensitivity 
through activation of peroxisome proliferator-activated receptors. 
The presence of vitamin E stabilizes low-density lipoproteins in the 
plasma, protecting them from oxidation, which is a symptom of ath-
erosclerosis, and a high intake of vitamin E has been associated with 
a lower risk of coronary heart disease in women and men (45,46). 
The breakdown and utilization of adipose tissue for energy during 
CR, which causes a decrease in both insulin and leptin, may result in 
a release of bound vitamin and cause an elevation of vitamin E and 
associated metabolites in the plasma, which then exerts its beneficial 
effects as an antioxidant and a signaling molecule. In fact, we saw 
that several vitamin E metabolites correlated significantly negatively 
with leptin.
Increases in B Vitamins May Be Improving Age-
Associated Declines in Cognition and Increased 
Oxidative Stress
Vitamin B5 (pantothenic acid) and the reduced form of vitamin B2 
(reduced riboflavin) increased with increasing CR and significantly 
discriminated between feeding groups in the O-PLS-DA. A deficiency 
of vitamins and minerals has been associated with increased mito-
chondrial decay and, due to the damaging effects of oxidative stress, 
aging (47). Deficiencies in vitamin B5, in particular, have been associ-
ated with increases in mitochondrial oxidation. Both reduced forms 
of vitamin B5 and B2 are required for the biosynthesis of heme, 
which is synthesized in the mitochondria, disruption of which can 
also contribute to mitochondrial decay and accumulation of iron 
(48). Specifically, vitamin B2 deficiencies have been seen in elderly 
human populations, and such insufficiencies have been associated 
with declining of cognitive function (49,50). This may be due to 
dietary deficiencies; however, it may also be due to inefficiencies 
in extracting nutrients from food. The increase in vitamins in the 
plasma observed here may suggest that nutritional breakdown and 
absorption is improved in CR animals, which may be associated 
with investment in the stomach and alimentary tract that we see 
in the high levels of CR (16). We found that derivatives of vitamin 
E metabolism and vitamin B2 correlated positively with stomach 
and colon weight and vitamin B5 correlated positively with stom-
ach weight. However, as well as percent reduction in calories, mice 
are receiving corresponding reductions in vitamin intake; therefore, 
increases in vitamin levels could also be characteristic of alterations 
in gut microbiota. CR has been shown to induce structural changes 
in gut microbiota in C57BL/6J mice that contribute to vitamin syn-
thesis, particularly B and K vitamins (51,52).
Several changes in C1 and methionine metabolism seen in our 
results suggest that CR is causing alterations in methionine, SAM, 
and folate metabolism in a dose-dependent manner. In particular, 
the increase in SAM and it’s cofactor vitamin B6 and concomitant 
decrease in precursor methionine, in addition to other constitu-
ents of the methionine pathway taurine and glutathione. A  pre-
vious study has shown that B6 deficiency results in low levels of 
SAM in the liver. These changes in the plasma, which are particu-
larly apparent at 40CR, further indicate a shift toward produc-
tion of the methyl-donor SAM. Increases in plasma SAM may be 
involved in methylation of DNA, proteins, neurotransmitters, and 
other cellular messengers, coordinating hunger signaling associ-
ated changes in the body. In addition, DNA methylation is hugely 
important for the control of gene expression, whereas hypometh-
ylation of DNA is seen with age and in aging-associated disorders, 
DNA methylation is thought to be strongly associated with lon-
gevity (53).
Pathways and Metabolites Associated With Lipid 
β-Oxidation Conserved Between the Plasma 
and Liver
When we looked at circulating metabolites that had the most 
important impact on discrimination between the CR treatment 
groups, both sphinganine-1-phosphate and sphinganine were 
among these metabolites. Sphinganine significantly increased with 
increasing CR and sphinganine-1-phosphate was increased in all 
CR groups. We previously observed that in the liver the sphingo-
lipid/ceramide ratio was a significant part of the hepatic metabo-
lome remodeling with CR (12). Though phospholipid metabolism 
appears less prominent in the plasma, these metabolites were 
shown to be increased, as sphingosine-1-phosphate was in the 
liver, indicating that these metabolites may be secreted into the 
plasma where they may ultimately be involved in hunger signal-
ing, reducing inflammation and lipid homeostasis. Previous study 
suggested that in the hypothalamus, S1P regulates energy homeo-
stasis in rats. Microinjection of S1P into the third ventricle of rats 
increased body temperature and energy expenditure, and micro-
injection of S1PR1 agonist SEW2871 decreased food intake and 
activated leptin signaling (54). However, we previously found that 
when injected peripherally S1P has no effect on body temperature 
(Tb), food intake, or energy expenditure (12). Furthermore, the 
fatty acid neurotransmitter and member of the endocannabinoid 
family anandamide was increased at 20CR, 30CR, and 40CR and 
has recently been shown to act in the hypothalamus via cannabin-
oid receptors to control feeding behavior (55). In obese animals, 
levels of anandamide and other endocannabinoids are increased in 
both the brain and periphery and administration promotes over-
eating (56–58). Anandamide may then be part of a suite of per-
ipheral signals produced under restriction that signal the energy 
balance status to the brain. Signals such as these may in some part 
explain behaviors such as food anticipatory activity and reduced 
body temperature in restricted animals (59). Indeed, we saw that 
anandamide correlated negatively with average Tb over the last 2 
weeks of restriction and positively with food anticipatory activity 
over the same period. However, despite the elevated levels of anan-
damide, we did not detect any evidence for elevated cannabinoid 
signaling in the hypothalami of the same mice (25).
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Carnitines, increases of which we previously saw in the liver, also 
increase in the plasma (12), several of which correlated positively 
with level of CR. Carnitine shuttles long-chain fatty acids across the 
mitochondrial membrane for β-oxidation and can reduce oxidative 
stress by preventing the accumulation of toxic long-chain fatty acyl-
CoA metabolites (60). Pathway analysis indicated carnitine shuttle 
components were increased with CR; however, in contrast to the liver, 
l-carnitine appeared significantly decreased at 40CR. As l-carnitine 
shuttles long-chain fatty acids across the mitochondrial membrane, 
and mammalian red blood cells do not contain mitochondria, l-carni-
tine may be moving from the plasma into the liver and muscle for use 
in fatty acid oxidation. We found that the levels of O-acetylcarnitine, 
which increased with increasing CR, correlated positively with levels 
of O-acetylcarnitine in the liver. As carnitines have been implicated 
in insulin sensitivity and inflammation, it may be that carnitine has a 
distinct role in the plasma compared with the liver (61).
Although taurine, a constituent of bile, was reduced with increas-
ing CR, circulating levels of 7α-hydroxycholesterol, 5β-cholestane-
3α,7α-diol, 5β-cholestane-3α,7α,26-triol, 5β-cyprinolsulfate, and 
7α-hydroxy-3-oxo-4-cholestenoate, which are involved in primary 
bile acid synthesis, showed a graded increase with increasing CR 
and were all decreased at 24AL. This may indicate that the plasma, 
although not involved in lipid breakdown, transports the constit-
uents of bile acids to organs such as the liver, whereas products, 
such as taurine, are secreted into the plasma for disposal. In the gut, 
bile acids break down large fat globules into smaller droplets and 
promote their absorption through formation of micelles. This helps 
stimulate energy metabolism and improves insulin sensitivity (62). 
CR has been shown to reverse the decline in the bile acid synthe-
sis pathway with age in female C57BL/6 mice (63). There is also 
increasing evidence that bile acids play a role as signaling molecules 
through G-protein-coupled receptors in the liver and may result in 
amelioration of obesity and diabetes in mice (64).
We saw a decrease in glucose at 30CR and 40CR and a graded 
increase in the fatty acid-CoA molecules, 3-hydroxyoctadecanoyl-
CoA and 2-hydroxyphytanoyl-CoA, which indicates a shift toward 
the fatty acid entry to the citric acid cycle and away from glycolysis. 
As with l-carnitine, these molecules may be in transit to the liver or 
muscles for breakdown. This result is consistent with the theory that 
CR results in metabolic reprogramming involving a move away from 
glycolysis and toward fatty acid β-oxidation.
However, we saw no significant changes in metabolites involved 
in both the urea cycle and production of ketone bodies, two pro-
cesses commonly associated with breakdown of amino acids and fatty 
acid oxidation during acute starvation (65,66). There may be several 
explanations for this. First, some of the products of amino acid metab-
olism and ketogenesis were too small to be detected. For example, 
urea (MW = 60.06) and acetone (MW = 58.09) were both below the 
approximate MW detection limit of 85 for the liquid chromatog-
raphy–mass spectrometry we used. However, other products of these 
pathways were large enough to be detected. We did detect l-arginine 
(MW = 174.2) and l-citrulline (MW = 175.2) but neither were corre-
lated with the levels of restriction. We did not detect the main ketones, 
acetoacetate and β-hyroxybutyrate, despite the sizes of these com-
pounds being detectable (MW 102 and 104, respectively). This sug-
gests that ketogenesis was minimal. Although this seems to contrast 
with several other studies, the previous study involved mice undergo-
ing much shorter periods of CR (15,66) relative to the 3 months in 
the present study. This is important as the mice in our study showed 
two distinct stages of metabolic response: a dynamic phase when both 
fat and lean tissues were withdrawn, which lasted about 30 days, fol-
lowed by a period of stability when body weight and composition 
were constant (16). During this period, the mice were back in energy 
balance between their energy demands and their ingested food, which 
was predominantly carbohydrate. Because the mice were sampled 
after 60  days in this stable phase, we would not expect significant 
utilization of amino acids or triglycerides from the tissues to still be 
occurring. Consequently, we would also not anticipate significant lev-
els of the byproducts of amino acid degradation, and ketone bodies 
in the plasma. This was also consistent with the absence of signifi-
cant changes in such compounds in the liver metabolome of the same 
mice (12). Although there does appear evidence of significant upregu-
lation of β-oxidation of fatty acids in these mice (29,67), this was 
also matched by upregulation of the hepatic  tricarboxylic acid (TCA) 
cycle activity, and this may explain why ketones were not generated in 
significant amounts from fatty acid oxidation. When individuals reach 
steady state, it is likely there is a cycle in metabolite usage through the 
24-hour day. This would require a dependence on carbohydrates via 
glycolysis directly from the food during the night, combined with sig-
nificant lipogenesis to convert ingested CHO to stored fat (68), which 
can then be utilized via β-oxidation during the day, probably supple-
mented by gluconeogenesis, once the food has run out, which was the 
time point at which we sacrificed them. Finally, metabolite detection 
between the serum and plasma differs significantly in humans and 
rats, in particular concentrations of metabolites tend to be smaller in 
the plasma than in the serum, which has been attributed to the vol-
ume displacement effect. In particular, ornithine (urea cycle), arginine 
(urea cycle), arachidonic acid (phospholipid), and β-hydroxybutyrate 
(ketone body) are lower in the plasma than in the serum (69,70).
Distinct Differences Exist at 24AL and at Differing 
Levels of CR
As can be seen in Figure  5, metabolic pathway changes were not 
consistent across treatment groups, and although some metabolites 
and pathways have a linear relationship with CR, others do not. 
A particular absence of significant pathways appears at 20CR, which 
may indicate a threshold level for metabolic effects, prior to a range 
of significant changes at 30CR and 40CR. This is consistent with 
previous metabolic analyses in the liver, which indicated that the 
relationship between CR and metabolite level is not always linear 
(6). What is particularly of note is the large number of significantly 
altered pathways at both 10CR and 40CR, of which there are very 
few overlaps, which may indicate a stable state shift at the extremi-
ties, with greater flux in pathway changes between 20CR and 30CR.
Pathway analyses indicated that many pathways significantly 
altered in 24AL are unmistakeably different from those of the CR 
groups (Figure 5). Several of these pathways were associated with 
cancer, including thyroid and lung cancer cell signaling and wnt/β 
cantenin signaling, this suggests metabolites that are being altered 
in the 24AL group may be involved in tumorigenesis. Many of the 
other significant pathways involved fatty acid metabolism, including 
glycerophospholipid, linoleate, and omega-3 fatty acid metabolism 
and fatty acid activation were altered. In addition to this, we saw 
changes in vitamin B9, vitamin A, vitamin E metabolism as well as 
sialic acid and selanoamino metabolism.
It is important to note that changes in metabolic pathways may 
also depend on the strain of mouse, as the longevity impact of CR 
and changes in the metabolome are known to be related to genetic 
background (6,71). In addition, although we only used male mice 
in this study, sex differences in the metabolic profiles of male and 
Journals of Gerontology: BioloGical ScienceS, 2019, Vol. 74, No. 1 23
D
ow
nloaded from
 https://academ
ic.oup.com
/biom
edgerontology/article-abstract/74/1/16/4990507 by U
niversity of Aberdeen user on 21 D
ecem
ber 2018
female mice have been observed, in particular, in groups of metabo-
lites such as the BCAAs (6,72).
Conclusion
Circulating levels of sphingolipids, carnitines, and bile acids were all 
significantly altered in the plasma with CR, many showing a graded 
effect, reflecting similar changes observed previously in the livers of 
the same mice (12). Changes in the components of these pathways 
with CR, however, appeared less significant than in the liver, possibly 
due to the primary transport role of plasma. As seen previously, many 
of the metabolites were altered in a graded fashion, highlighting their 
potential relevance to longevity. In contrast to the smaller effects in 
plasma of sphingolipids, carnitines, and bile acids, the amino acids 
showed greater changes in the plasma than in the liver. BCAAs were 
all decreased in the plasma, consistent with previous suggestions that 
reduced BCAAs reduce insulin resistance and fasting glucose. We also 
saw notable changes in the circulating levels of vitamins, with nearly 
every major group being elevated at higher levels of CR despite their 
dietary supply being reduced. This included several elements of the 
vitamin E complex and most B vitamins. This result may be due to 
an increasing efficiency of the gut through investment in size and 
changes in gut microbiota to breakdown and absorb key nutrients 
from their limited food intake. Increased vitamin E is associated with 
improved mitochondrial and membrane function, which supports 
the suggestion that CR may improve metabolism through promoting 
utilization of lipids during CR and regulating energy homeostasis.
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